Latest long-term debt for ITOS: $3.6M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
ITeos Therapeutics (ITOS) currently reports a long-term debt of $3.6M as of June 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore ITeos Therapeutics's long-term debt history and peer comparisons.
ITeos Therapeutics's long-term debt changed from $0 to $3.6M (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
ITeos Therapeutics reported $3.6M in long-term debt as of June 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current long-term debt of $3.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ITeos Therapeutics, and consider following ITOS for alerts when major investors trade the stock.
ITeos Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $3.6M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ITOS with unrelated industries.